drugset / Trial / NCT01708707

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

NCT01708707

Phase 2 Completed 29 enrolled Pediatrix
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to determine whether buprenorphine is a beneficial, safe, cost effective treatment alternative to morphine sulfate in the treatment of Neonatal Abstinence Syndrome (NAS).

Timeline

Start
2012-12
Primary completion
2017-10
Completion
2017-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 15.9 ug/kg Other
Comparator Morphine Other / unclassified 0.4 mg/kg Oral